- 藥品外觀
- 劑量及用法IV: 50-100 mg/M2/day on day 1-5 or 100 mg/M2 on day 1, 3, 5 q3-4wk in combination with other drugs. Dosage should be modiFied to consider the myelosuppressive eFFects oF combined drugs or x-ray therapy.
- 劑量調整
- 最大劑量
- 注射劑配製時溶液限制
- 品牌Fresenius Kabi
- 許可證號衛署藥輸字第024638號藥品仿單查詢平台
- 健保代碼BC24638221健保規範查詢
- 健保給付規定
- ATC碼L01CB01
- ATC藥理分類


